Precision Biosciences

DTILNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$179.410 M

$6.50 -2.55%

Close of 21 Sept 2026

Revenue

$34.3M

#2845 by revenue

Earnings

-$45.7M

Loss-making

Shares outstanding

27,601,554

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#100Voyager TherapeuticsVYGR$189.8M
#101Acumen PharmaceuticalsABOS$187.3M
#102Precision BiosciencesDTIL$179.4M
#103Outlook TherapeuticsOTLK$167.1M
#104HumacyteHUMA$163.9M

What if Precision Biosciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,096,824

Per share 168,742× higher

Bitcoin $1.72T

$62,308.22

Per share 9,586× higher

Nvidia $5.48T

$198,534.40

Per share 30,544× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Precision Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.